✦ LIBER ✦

Effects of potent vitamin D3 analogs on clonal proliferation of human prostate cancer cell lines

✍ Scribed by de Vos, Sven; Holden, Stuart; Heber, David; Elstner, Elena; Binderup, Lise; Uskokovic, Milan; Rude, Bob; Chen, Dan Lin; Le, Jennifer; Cho, Steve K.; Koeffler, H. Phillip

Publisher: John Wiley and Sons
Year: 1997
Tongue: English
Weight: 328 KB
Volume: 31
Category: Article
ISSN: 0270-4137
DOI: 10.1002/(sici)1097-0045(19970501)31:2<77::aid-pros1>3.0.co;2-e

No coin nor oath required. For personal study only.

✦ Synopsis

Background:

Management of prostate cancer that has spread outside of the prostate capsule is a difficult problem. innovative, non-toxic approaches to the disease are required. new, relatively non-toxic vitamin d3 analogs have recently been synthesized. we report that several of these compounds have marked antiproliferative effects on prostate cells.

Methods:

The clonal antiproliferative activity of five novel analogs of 1,25 dihydroxyvitamin d3 [1,25(oh)2d3, (cmpd c)] as well as 1,25(oh)2d3 itself was tested on three human prostate cancer cell lines (pc-3, lncap, and du-145). the analogs were 20-epi-22oxa-24a,26a,27a-tri-homo-1 alpha,25(oh)2d3 (code name: kh 1060); 24a26a27a-tri-homo-22,24-diene-1 alpha,25(oh)2d3 (code name: eb 1089); 1,25(oh)2-16ene-d3 (code name: hm); 1,25(oh)2-16ene-23yne-d3 (code name: v); 1,25(oh)2-20-epi-d3 (code name: mc 1288)].

Results:

With the parent compound [1,25(oh)2d3], the effective dose that inhibited 50% clonogenic growth of pc-3 and lncap was 10(-8)m and 7 x 10(-9)m, respectively. for these prostate cancer cell lines, kh 1060 was the most potent analog by an order of 25- to 35-fold as compared to cmpd c. the second and third most potent analogs were hm and mc 1288. du-145 was resistant to all the vitamin d3 analogs. the major side-effect of 1,25(oh)2d3 is the production of hypercalcemia. the relative inhibitory index (rii) was determined by comparing the antiproliferative activity of the analog to its ability to produce hypercalcemia in mice injected intraperitoneally every other day. the kh 1060 had the best rti: 50- to 70-fold greater than 1,25(oh)2d3 for pc-3 and lncap, respectively.

Conclusions:

A trial of one or more of these innovative compounds should be considered for treatment of minimal residual disease of prostate cancer.

📜 SIMILAR VOLUMES

Effect of bone proteins on human prostat

Effect of bone proteins on human prostate cancer cell lines in vitro

✍ Hullinger, Thomas G.; McCauley, Laurie K.; DeJoode, Melanie L.; Somerman, Martha 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 290 KB 👁 2 views

## Background: Despite the high incidence and serious consequences of skeletal metastasis in prostate cancer patients, the mechanisms involved in establishing secondary lesions in bone are not well-understood. in this study, the role of the mineralized bone matrix in the process of skeletal metasta

Vitamin D3 analogs and their 24-Oxo meta

Vitamin D3 analogs and their 24-Oxo metabolites equally inhibit clonal proliferation of a variety of cancer cells but have differing molecular effects

✍ Moray J. Campbell; G. Satyanarayana Reddy; H. Phillip Koeffler 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 183 KB

The seco-steroid hormone, 1a,25 dihydroxyvitamin D 3 (1a,25(OH) 2 D 3 ) binds to a specific nuclear receptor that acts as a ligand-inducible transcription factor. The resulting genomic effects include partial arrest in G 0 /G 1 of the cell cycle and induction of differentiation; these effects have b

Novel 20-epi-vitamin D3 analog combined

Novel 20-epi-vitamin D3 analog combined with 9-cis-retinoic acid markedly inhibits colony growth of prostate cancer cells

✍ Elstner, Elena; Campbell, Moray J.; Munker, Reinhold; Shintaku, Peter; Binderup, 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 301 KB 👁 1 views

BACKGROUND. 1,25 dihydroxyvitamin D 3 (1,25D) and retinoids may play an important role in preventing progression of prostate cancer. METHODS. We examined the ability of four novel 20-epi-vitamin D 3 analogs (CB1093, KH1060, KH1266, and CB1267), either alone or in combination with 9-cis retinoic acid

Effect of stromal and epithelial cells d

Effect of stromal and epithelial cells derived from normal and tumorous breast tissue on the proliferation of human breast cancer cell lines in co-culture

✍ Xuefen Dong-Le Bourhis; Yolande Berthois; Guy Millot; Armelle Degeorges; Monique 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 318 KB 👁 2 views

Growth-inhibitory effects of luteinizing

Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice

✍ Donatella Dondi; Roberta M. Moretti; Marina Montagnani Marelli; Graziella Prates 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 1 views

Experiments have been performed to clarify whether LHRH agonists might decrease growth of hormone-unresponsive prostate cancer in vivo. Male nude mice were injected s.c. with the human androgen-independent prostate tumor DU 145 cells; osmotic minipumps releasing the LHRH agonist Zoladex (LHRH-A) for

Detrimental effect of cancer preventive

Detrimental effect of cancer preventive phytochemicals silymarin, genistein and epigallocatechin 3-gallate on epigenetic events in human prostate carcinoma DU145 cells

✍ Neehar Bhatia; Rajesh Agarwal 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 250 KB

## Background: Targeting epigenetic events associated with autonomous growth of advanced prostate cancer (pca) is a practical approach for its control, prevention, and treatment. recently we showed that treatment of prostate carcinoma du145 cells with cancer preventive flavonoid silymarin at 100-20